Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo.

Mpanya A, Hendrickx D, Vuna M, Kanyinda A, Lumbala C, Tshilombo V, Mitashi P, Luboya O, Kande V, Boelaert M, Lefèvre P, Lutumba P.

PLoS Negl Trop Dis. 2012 Jan;6(1):e1467. doi: 10.1371/journal.pntd.0001467. Epub 2012 Jan 17.

2.

From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.

Mpanya A, Hendrickx D, Baloji S, Lumbala C, da Luz RI, Boelaert M, Lutumba P.

PLoS Negl Trop Dis. 2015 Apr 9;9(4):e0003686. doi: 10.1371/journal.pntd.0003686. eCollection 2015 Apr.

3.

Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo.

Robays J, Lefèvre P, Lutumba P, Lubanza S, Kande Betu Ku Mesu V, Van der Stuyft P, Boelaert M.

Trop Med Int Health. 2007 Feb;12(2):290-8.

4.

Treatment outcomes for human African Trypanosomiasis in the Democratic Republic of the Congo: analysis of routine program data from the world's largest sleeping sickness control program.

Hasker E, Mpanya A, Makabuza J, Mbo F, Lumbala C, Kumpel J, Claeys Y, Kande V, Ravinetto R, Menten J, Lutumba P, Boelaert M.

Trop Med Int Health. 2012 Sep;17(9):1127-32. doi: 10.1111/j.1365-3156.2012.03042.x. Epub 2012 Jul 19.

5.

Knowledge, behaviours, practices and beliefs regarding Human African Trypanosomiasis (HAT) among inhabitants of Kinshasa (Democratic Republic of Congo).

Tshimungu K, Kalambayi BB, Kiyombo M, Okenge LN, Mol PD.

Sante. 2008 Jul-Sep;18(3):141-7. doi: 10.1684/san.2008.0119. Erratum in: Sante. 2008 Oct-Dec;18(4):186.

PMID:
19359235
6.

Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk.

Lumbala C, Simarro PP, Cecchi G, Paone M, Franco JR, Kande Betu Ku Mesu V, Makabuza J, Diarra A, Chansy S, Priotto G, Mattioli RC, Jannin JG.

Int J Health Geogr. 2015 Jun 6;14:20. doi: 10.1186/s12942-015-0013-9.

7.

High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo.

Robays J, Nyamowala G, Sese C, Betu Ku Mesu Kande V, Lutumba P, Van der Veken W, Boelaert M.

Emerg Infect Dis. 2008 Jun;14(6):966-7. doi: 10.3201/eid1406.071266.

8.

The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo.

Robays J, Bilengue MM, Van der Stuyft P, Boelaert M.

Trop Med Int Health. 2004 May;9(5):542-50.

9.

In the heart of darkness: sleeping sickness in Zaire.

Ekwanzala M, Pépin J, Khonde N, Molisho S, Bruneel H, De Wals P.

Lancet. 1996 Nov 23;348(9039):1427-30.

PMID:
8937285
10.

Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo.

Mitashi P, Hasker E, Mbo F, Van Geertruyden JP, Kaswa M, Lumbala C, Boelaert M, Lutumba P.

Trop Med Int Health. 2015 Jan;20(1):98-105. doi: 10.1111/tmi.12404. Epub 2014 Oct 20.

11.

Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo.

Hasker E, Lumbala C, Mbo F, Mpanya A, Kande V, Lutumba P, Boelaert M.

Trop Med Int Health. 2011 Jul;16(7):869-74. doi: 10.1111/j.1365-3156.2011.02772.x. Epub 2011 Mar 29.

12.

Human African trypanosomiasis in a rural community, Democratic Republic of Congo.

Lutumba P, Makieya E, Shaw A, Meheus F, Boelaert M.

Emerg Infect Dis. 2007 Feb;13(2):248-54.

13.

Trypanosomiasis control, Democratic Republic of Congo, 1993-2003.

Lutumba P, Robays J, Miaka mia Bilenge C, Mesu VK, Molisho D, Declercq J, Van der Veken W, Meheus F, Jannin J, Boelaert M.

Emerg Infect Dis. 2005 Sep;11(9):1382-8.

14.

Sleeping sickness in Zaire.

van Hove D.

Lancet. 1997 Feb 8;349(9049):438. No abstract available.

PMID:
9033508
15.

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.

Priotto G, Kasparian S, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Karunakara U.

Clin Infect Dis. 2007 Dec 1;45(11):1435-42. Epub 2007 Oct 22.

16.

Human African trypanosomiasis transmission, Kinshasa, Democratic Republic of Congo.

Simo G, Mansinsa Diabakana P, Kande Betu Ku Mesu V, Manzambi EZ, Ollivier G, Asonganyi T, Cuny G, Grébaut P.

Emerg Infect Dis. 2006 Dec;12(12):1968-70.

17.

African sleeping sickness in the United States. Successful treatment with eflornithine.

Petru AM, Azimi PH, Cummins SK, Sjoerdsma A.

Am J Dis Child. 1988 Feb;142(2):224-8.

PMID:
3124603
18.

[An epidemiological survey to discover the probable places of infection with sleeping sickness in the Central African Republic].

Gouteux JP, Kounda Gboumbi JC, D'Amico F, Wagner C, Noutoua L, Bailly C.

Bull World Health Organ. 1993;71(5):605-14. French.

19.

[Re-emergence of human African trypanosomiasis in Kinshasa, Democratic Republic of Congo (DRC)].

Tshimungu K, Okenge LN, Mukeba JN, de Mol P.

Med Mal Infect. 2010 Aug;40(8):462-7. doi: 10.1016/j.medmal.2009.12.007. Epub 2010 Jan 15. French.

PMID:
20079989
20.

Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo.

Tong J, Valverde O, Mahoudeau C, Yun O, Chappuis F.

Confl Health. 2011 May 26;5:7. doi: 10.1186/1752-1505-5-7.

Items per page

Supplemental Content

Write to the Help Desk